Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Kingfisher’s chronic wound healing device receives CE Mark

Kingfisher Healthcare : 13 March, 2008  (New Product)
Kingfisher Americas, a subsidiary of the Belgium-based Kingfisher Healthcare, has received the CE mark for its KFH Novo medical device, a breakthrough medical technology that enhances the healing of chronic wounds.
KFH Novo is the latest addition to Kingfisher's line of safe, non-invasive energy therapies designed to treat patients suffering from a range of chronic conditions.

KFH Novo utilises Kingfisher's Bio-Electric Stimulation Therapy (BEST) to assist in and improve upon the healing of chronic wounds including venous leg ulcers, diabetic ulcers and pressure sores. The form of electrotherapy enhances the physiological processes of wound healing at a cellular level, increasing protein synthesis levels, stimulating angiogenesis and fibroblasts, and increasing levels of ATP production to restart and regenerate tissue healing.

'Treatments for chronic wounds remain a major clinical challenge as a significant number of patients endure painful, open abrasions for as long as a year,' said Dr Henk Snyman, founder and chief executive officer of Kingfisher Healthcare. 'We are thrilled to offer physicians and patients a safe, non-invasive and cost-effective therapy designed to successfully treat several types of chronic wounds.'

Designed for home use, KFH Novo is portable, convenient and easy-to-use. The device’s sleek and modern design elements, including patented touch-screen panel, allows patients to monitor and control their treatments. KFH Novo is expected to enter the USA market in 2009.

'We are pleased to announce the addition of KFH Novo to our line of innovative, alternative therapies,' said Herb Whitaker, chief executive officer of Kingfisher Americas. 'We look forward to working with the European medical community to introduce this unique therapy intended to significantly improve upon each patient's quality of life.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo